Atlas Trials

Immunogenicity and Safety of DCs in Breast Cancer

Clinical trial NCT03450044 · COMPLETED

Trial details

NCT number
NCT03450044
Sponsor
Fundación Salud de los Andes
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer Female
Start date
2014-01-01
Primary completion
2018-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.